GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Johnson & Johnson JNJ · USD

Health Care · Pharmaceuticals · US listing · 🇺🇸 United States

S&P 500Dow Jones

Compare

276.22

+1.43%

Close of 6 Nov 2026, in USD

Analyst ratings

30 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 7Strong buy
  • 14Buy
  • 9Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 276.22Average target 282.08

Low
255.00
Average
282.08
Median
282.00
High
305.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$101.21bn$107.88bn$116.67bn$125.59bn$135.57bn
Revenue, highest$101.48bn$109.54bn$120.16bn$127.33bn$137.45bn
Revenue, lowest$100.83bn$105.98bn$113.95bn$124.18bn$134.05bn
Earnings per share11.1111.6013.9715.7117.70
Earnings per share, highest11.2012.3215.5616.0018.02
Earnings per share, lowest11.0410.6913.4415.4917.44
Analysts161618917

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast2.562.872.692.462.782.712.612.03
Reported2.592.902.702.462.802.772.772.04
Difference+1.0%+0.9%+0.3%-0.1%+0.5%+2.3%+6.0%+0.7%

Rating changes

Latest broker notes

  • GuggenheimBuy
  • Wells FargoOverweight
  • GuggenheimBuy
  • Wells FargoOverweight
  • RBC CapitalOutperform
  • Raymond JamesOutperform
  • Morgan StanleyOverweight
  • TD CowenBuy
  • RBC CapitalOutperform
  • B of A SecuritiesNeutral
  • Morgan StanleyOverweight
  • CitigroupBuy

Recent targets

Latest 12 months

  • HSBC320.00
  • UBS320.00
  • Guggenheim287.00
  • Raymond James280.00
  • Wells Fargo282.00
  • Argus Research300.00
  • Johnson Rice280.00
  • Scotiabank305.00

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 3.0% a year over 10 years. Return on equity 32.9%.

Model fair value

236.99

From earnings 236.99, from revenue 195.02.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.